These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5381991)

  • 1. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].
    Büsing CM; Heyck H; Laudahn G
    Klin Wochenschr; 1969 Oct; 47(20):1099-103. PubMed ID: 5381991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for the release of enzymes from different organs in Duchenne's muscular dystrophy.
    Kleine TO
    Clin Chim Acta; 1970 Aug; 29(2):227-31. PubMed ID: 4321812
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 10. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma changes of some enzyme activities in myocardial infarct].
    Di Febo G; Corinaldesi R; Cornia GL; Maccolini E; Luchetta L; Busca G
    Minerva Cardioangiol; 1974; 22(7-8):543-51. PubMed ID: 4410411
    [No Abstract]   [Full Text] [Related]  

  • 12. The diagnostic significance of serum enzymes and electrocardiogram in various muscular dystrophies.
    Zellweger H; Durnin R; Simpson J
    Acta Neurol Scand; 1972; 48(1):87-101. PubMed ID: 5019834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum enzyme alterations in neuromuscular disorders.
    Munsat TL; Baloh R; Pearson CM; Fowler W
    JAMA; 1973 Dec; 226(13):1536-43. PubMed ID: 4800933
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of exercise on serum enzymes.
    Fowler WM; Gardner GW; Kazerunian HH; Lauvstad WA
    Arch Phys Med Rehabil; 1968 Oct; 49(10):554-65. PubMed ID: 5685050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term hypertransaminasemia disclosing a muscular disease].
    Odièvre M; Rivron M; Landrieu P
    Arch Fr Pediatr; 1987; 44(6):453-4. PubMed ID: 3619584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-biochemical and genetic studies of myopathy].
    Davidenkova EF; Droznina TA; Markelov IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.